Immix Biopharma (IMMX) Treasury Shares (2022 - 2026)

Immix Biopharma has reported Treasury Shares for 5 years, with the latest figure at $99963.0 in Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $99963.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99963.0 (changed 0.0% YoY) and the FY2025 annual result came in at $99963.0, changed 0.0% from the prior year.
• Treasury Shares was little changed at $99963.0 in Q1 2026 per IMMX's latest filing, from $99963.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $72363.0 in Q4 2022 and troughed at -$72363.0 in Q4 2023.
• A 5-year average of $4677.2 and a median of $37418.0 in 2022 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 78.62% in 2023, down 0.0% in 2023.
• Over 5 years, Treasury Shares stood at $99963.0 in 2022, then changed by 0.0% to $99963.0 in 2023, then changed by 0.0% to $99963.0 in 2024, then changed by 0.0% to $99963.0 in 2025, then changed by 0.0% to $99963.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $99963.0, $99963.0, and $99963.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.